Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Foamix and Therapeutics collaborate to develop inflammatory skin disease therapies

March 5, 2010

Biomoda and Amigenics announce collaboration

March 5, 2010

Solasia and Kyowa Hakko Kirin license agreement for SP-01 in Asia

March 4, 2010

Lilly and Transition Therapeutics enter into licensing and collaboration agreement

March 4, 2010

NicOx grants Bausch & Lomb worldwide rights to NCX-116

March 4, 2010

Seattle Genetics achieves milestone under antibody-drug conjugate collaboration with Genentech

March 4, 2010

Bristol-Myers Squibb and Allergan enter global agreement on ExonHit's AGN-209323

March 4, 2010

Nabi stockholders approve NicVAX option and license agreement

March 4, 2010

Abbott and Enanta advance their hepatitis C collaboration

March 3, 2010

Lundbeck inlicenses marketing rights to Azilect in Asian countries

March 3, 2010

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...